Physician profile
Arash Calafi
NPI 1164866935
$2,931.56
in general payments reported to CMS, 2019-2025
13 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $554 · 2021: $23.54 · 2022: $359 · 2023: $576 · 2024: $198 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Travel and Lodging: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.59 |
| Travel and Lodging | $149.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $690.49 | 2020-2025 | Profyle, Variax, Axsos |
| Sportstek Medical, INC | $436.00 | 2019 | |
| Arthrex, INC. | $411.29 | 2020 | |
| Smith+Nephew, INC. | $282.07 | 2019 | |
| Paragon 28, INC. | $281.83 | 2023 | Portfolio, Monkey Rings |
| Zimmer Biomet Holdings, INC. | $197.66 | 2025 | Comprehensive Shoulder System |
| Treace Medical Concepts, INC. | $146.56 | 2022 | |
| Wright Medical Technology, INC. | $134.39 | 2019 | |
| Depuy Synthes Sales INC. | $112.81 | 2022 | |
| Sanara Medtech INC. | $97.27 | 2022-2024 | Celleraterx |
| Osteocentric Technologies, INC. | $68.38 | 2020-2021 | |
| Extremity Medical | $56.82 | 2024 | |
| Impactortho, INC. | $15.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Calafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.